The large-scale analysis carried out by researchers at La Trobe University and published in heart found that many Australians living with CHD are below recommended prescription medications, are not seen as major risk factors and have treatments that do not achieve the recommended goals. In particular, women and those under the age of 45 are more likely to be under-treated compared to similarly affected men and elderly people.
The study, led by epidemiologist La Trobe Professor Rachel Huxley, analyzed GP records of 130,926 patients with a history of CHD from 2014-2018. Findings include:
- Women are less likely to be prescribed with any of the four recommended drugs for CHD, namely anti-aggregates, ACE inhibitors, beta-blockers and statins.
- Of the four drugs recommended for daily use, only about 22% of women and 34% of men were prescribed in all four
- In contrast, 21% of women and 10% of men did not appoint any of these four medicines
According to the Australian Institute of Health and Well-being for 2015, 44% of all IBS deaths are women, and IBS remains the leading cause of female deaths in Australia.
"There is a widespread prediction that IBS only affects older men, but nearly half of those who die from the disease are women," says Professor Huxley.
"Our study shows that people with a history of CHD, especially women and people under the age of 45, are less likely to cope with their condition in line with current clinical guidelines. goals than men. "
Professor Huxley said that the differences in sexual management of IBS in primary care are needed to improve outcomes for all affected people and their families.
The National Heart Foundation welcomes the latest findings. Foundation Director of Prevention, Ms. Julie Anne Mitchell, said research has consistently emphasized that women are "invisible when it comes to heart disease."
"Heart health checkups, lifestyle changes, and appropriate medicines are just as important to women as for men, and these findings cause all clinicians to take this into account when assessing patients," Mitch Mitchell said.
"The Australian study highlights that the overall healthcare costs of women with heart disease are less than half of those spent on men, and this latest study shows once again why we need to redress the imbalance," she said.
The study is funded by the Australian National Heart Foundation Vanguard Grant, with data available from the Medicine Insight, a GP national GP program.
Source of History:
Materials provided by La Trob University, Note: Content can be edited for style and length.